Expertise in the R&D of natural sodium channel blocker molecules derived from microalgae, with multiple potential therapeutic indications. The molecule is small, allowing topical applications, with reversible effect, and no damage to living tissues. Strong IP portfolio with granted patents (14 countries).
www.algenis.com
www.algenis.com
Location: Argentina, Santiago del Estero